New treatment eliminates bladder cancer in 82% of patients

Photo credit: Tima Miroshnichenko via Pexels. Keck Medicine of USC – August 13, 2025. Research article: Journal of Clinical Oncology.

LOS ANGELES — A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment. In the majority of cases, the cancer disappeared after only three months of treatment, and almost half the patients were cancer-free a year later. […]

Click here to view original web page at www.news.keckmedicine.org

Related articles:

New treatment eliminates bladder cancer in 82% of patients – EurekAlert!

5 things we now know about bladder cancer – Johnson & Johnson

New Bladder Cancer Device Clears Tumors In Most Patients, No Surgery Needed – StudyFinds